| Primary |
| Product Used For Unknown Indication |
13.5% |
| Pyrexia |
11.5% |
| Drug Use For Unknown Indication |
8.7% |
| Neck Pain |
6.7% |
| Pain |
6.7% |
| Headache |
5.8% |
| Dysmenorrhoea |
4.8% |
| Analgesic Therapy |
3.8% |
| Ankylosing Spondylitis |
3.8% |
| Arthralgia |
3.8% |
| Arthritis |
3.8% |
| Influenza |
3.8% |
| Pain In Extremity |
3.8% |
| Anal Injury |
2.9% |
| Back Pain |
2.9% |
| Diabetes Mellitus |
2.9% |
| Hypertension |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Viral Infection |
2.9% |
| Abdominal Pain Upper |
1.9% |
|
| Renal Failure Acute |
20.4% |
| Nausea |
7.4% |
| Neuritis |
5.6% |
| Stomatitis |
5.6% |
| Tubulointerstitial Nephritis |
5.6% |
| Urticaria |
5.6% |
| Vomiting |
5.6% |
| Anaphylactic Reaction |
3.7% |
| Colitis Ulcerative |
3.7% |
| Dependence |
3.7% |
| Depressed Level Of Consciousness |
3.7% |
| Dyspnoea |
3.7% |
| Generalised Oedema |
3.7% |
| Muscle Twitching |
3.7% |
| Oculomucocutaneous Syndrome |
3.7% |
| Product Quality Issue |
3.7% |
| Throat Irritation |
3.7% |
| Thrombocytopenia |
3.7% |
| Confusional State |
1.9% |
| Drug Exposure During Pregnancy |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
18.2% |
| Drug Use For Unknown Indication |
10.0% |
| Neck Pain |
9.1% |
| Dysmenorrhoea |
8.2% |
| Pyrexia |
8.2% |
| Headache |
7.3% |
| Diabetes Mellitus |
5.5% |
| Osteoporosis |
5.5% |
| Analgesic Therapy |
3.6% |
| Fibromyalgia |
3.6% |
| Antipyresis |
2.7% |
| Pain |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Abdominal Pain Upper |
1.8% |
| Antiinflammatory Therapy |
1.8% |
| Arthralgia |
1.8% |
| Arthritic Pains |
1.8% |
| Arthritis |
1.8% |
| Back Pain |
1.8% |
| Cough |
1.8% |
|
| Renal Failure Acute |
17.9% |
| Dependence |
10.3% |
| Anaphylactic Reaction |
7.7% |
| Depressed Level Of Consciousness |
5.1% |
| Idiopathic Thrombocytopenic Purpura |
5.1% |
| Intentional Overdose |
5.1% |
| Lip Swelling |
5.1% |
| Overdose |
5.1% |
| Product Quality Issue |
5.1% |
| Suicide Attempt |
5.1% |
| Vomiting |
5.1% |
| Confusional State |
2.6% |
| Drug Exposure During Pregnancy |
2.6% |
| Generalised Oedema |
2.6% |
| Hallucination |
2.6% |
| Hypersensitivity |
2.6% |
| Hypoaesthesia |
2.6% |
| Nausea |
2.6% |
| Off Label Use |
2.6% |
| Renal Failure |
2.6% |
|
| Concomitant |
| Rheumatoid Arthritis |
14.9% |
| Pain |
13.6% |
| Product Used For Unknown Indication |
13.0% |
| Drug Use For Unknown Indication |
9.7% |
| Knee Operation |
6.5% |
| In Vitro Fertilisation |
5.2% |
| Prostate Cancer |
4.5% |
| Supplementation Therapy |
3.9% |
| Asthma |
3.2% |
| Juvenile Arthritis |
3.2% |
| Ankylosing Spondylitis |
2.6% |
| Diabetes Mellitus |
2.6% |
| Head And Neck Cancer |
2.6% |
| Sedative Therapy |
2.6% |
| Breast Cancer |
1.9% |
| Contraception |
1.9% |
| Dysmenorrhoea |
1.9% |
| Headache |
1.9% |
| Nuclear Magnetic Resonance Imaging |
1.9% |
| Sciatica |
1.9% |
|
| Nephrogenic Systemic Fibrosis |
8.3% |
| Renal Failure Acute |
8.3% |
| Viith Nerve Paralysis |
8.3% |
| Radiation Injury |
6.3% |
| Sarcoidosis |
6.3% |
| Acetonaemia |
4.2% |
| Anaemia |
4.2% |
| Angioedema |
4.2% |
| Chest Pain |
4.2% |
| Hypercalcaemia |
4.2% |
| Influenza Like Illness |
4.2% |
| Lacunar Infarction |
4.2% |
| Melaena |
4.2% |
| Post Lumbar Puncture Syndrome |
4.2% |
| Rhabdomyolysis |
4.2% |
| Sepsis |
4.2% |
| Syncope |
4.2% |
| Tooth Loss |
4.2% |
| Uterine Cancer |
4.2% |
| Vasculitis |
4.2% |
|
